Abstract

BackgroundPain is inherent in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA) and traditionally considered to be of nociceptive origin. Emerging data suggest a potential role of augmented central pain mechanisms in subsets of patients, thus, valid instruments that can identify underlying pain mechanisms are needed. The painDETECT questionnaire (PDQ) was originally designed to differentiate between pain phenotypes. The objectives were to evaluate the psychometric properties of the PDQ in patients with inflammatory arthritis by applying Rasch analysis and to explore the reliability of pain classification by test-retest.MethodsFor the Rasch analysis 900 questionnaires from patients with RA, PsA and SpA (300 per diagnosis) were extracted from ‘the DANBIO painDETECT study’. The analysis was directed at the seven items assessing somatosensory symptoms and included: 1) the performance of the six-category Likert scale; 2) whether a unidimensional construct was defined; 3) the reliability and precision of estimates. Another group of 30 patients diagnosed with RA, PsA or SpA participated in a test-retest study. Intraclass Correlation Coefficients (ICC) and classification consistency were calculated.ResultsThe Rasch analysis revealed: (1) Acceptable psychometric rating scale properties; the frequency distribution peaked in category 0 except for item 5, threshold calibration >10 observations per category, no disorder in the category measures for all items, scale category outfit Mnsq <2.0, small distances (<1.4 logits) between thresholds for category 1, 2 and 3 for all items. (2) The principal component analysis supported unidimensionality; the standardized residuals showed that 53.7% of total variance was explained by the measure and the magnitude of first contrast had an eigenvalue of 1.5, no misfitting items, clinical insignificant different item hierarchies across diagnoses (DIF < 0.5 logits). (3) A targeted item-person map, person and item separation indices of 1.88(reliability = 0.78), and 13.04 (reliability = 0.99). The test-retest revealed: ICC: RA 0.86(0.56–0.96), PsA 0.96(0.74–0.99), SpA 0.93(0.76–98), overall 0.94(0.84–0.98). Classification consistency was: RA 70%, PsA 80%, SpA 90%, overall 80%.ConclusionThe results support that the PDQ can be used as a classification instrument and assist identification of underlying pain-mechanisms in patients suffering from inflammatory arthritis.

Highlights

  • Pain is inherent in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA) and traditionally considered to be of nociceptive origin

  • The results support that the painDETECT questionnaire (PDQ) can be used as a classification instrument and assist identification of underlying pain-mechanisms in patients suffering from inflammatory arthritis

  • This suggests that peripheral tissue inflammation significantly contributes to nociceptive pain generation in inflammatory arthritis [8], augmented central painprocessing may play a prominent role in persistent pain [6].there is a need for instruments that can assist in identifying patients with augmented central pain mechanisms and thereby help tailor an effective, individualised treatment

Read more

Summary

Introduction

Pain is inherent in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA) and traditionally considered to be of nociceptive origin. The objectives were to evaluate the psychometric properties of the PDQ in patients with inflammatory arthritis by applying Rasch analysis and to explore the reliability of pain classification by test-retest. Emerging evidence supports that there are striking pain phenotypic similarities between neuropathic pain and pain conditions characterised by augmented central pain processing; that is how patients express their symptoms of abnormal sensory perceptions and the quality of their pain [11] Based on this overlap, the PDQ has been used as indicator of augmented central pain processing in patients with osteoarthritis and fibromyalgia [12,13,14,15] and recently, the PDQ has been introduced in studies of pain mechanisms in patients with RA [16, 17] and SpA [18]. Large variation in the examined population e.g. with regard to disease severity and gender can ensure generalisability [23]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.